Synerga Fund Spolka Akcyjna Logo

Synerga Fund Spolka Akcyjna

Commercializes medical therapies globally using industrial property and copyrights for clinical use.

SNG | WAR

Overview

Corporate Details

ISIN(s):
PLMWTNS00010 (+1 more)
LEI:
259400FUSQOKWI6AY207
Country:
Poland
Address:
Kraków Grzegórzecka 67D/26, 31-559 Kraków
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Synerga.fund S.A. is a Polish company whose activities include the commercialization of medical therapies. The company's core operations focus on utilizing industrial property and copyrights to implement therapies in commercial clinical treatment. Key responsibilities involve the global marketing and scaling of these therapies, centered around building the international ONGENO brand. While its primary focus appears to be in the medical sector, some sources have also indicated the company's involvement in the financial sector, particularly with blockchain technology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Synerga Fund Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Synerga Fund Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Biotech R&D using a miniature pig model, offering CRO services and biomaterials to pharma.
South Korea 149300
Arterra Bioscience Logo
Develops natural active ingredients via biotechnology for cosmetic, pharma, and food sectors.
Italy ABS
ASUA Inc. Logo
Consulting and solutions provider enhancing logistics safety and efficiency with IoT and telecom.
Japan 246A
Licenses patented material IP (MST®) to create higher-performance, lower-power semiconductors.
United States of America ATOM
Atrae, Inc. Logo
Develops People Tech solutions for HR, including big data job sites and organizational analytics.
Japan 6194
Developing uranium and battery minerals for the nuclear energy and energy storage markets.
Australia N/A
BayCurrent, Inc. Logo
Comprehensive consulting on strategy, AI, and digital transformation for corporations and government.
Japan 6532
BenevolentAI Logo
An AI-powered drug discovery platform accelerating R&D for scientists and pharmaceutical partners.
United Kingdom BAI
BerGenBio Logo
Develops first-in-class AXL kinase inhibitors for cancer and severe respiratory infections.
Norway BGBIO
Bergman & Beving Logo
Acquires and develops niche companies with solutions for the industrial and construction sectors.
Sweden BERG

Talk to a Data Expert

Have a question? We'll get back to you promptly.